Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:43 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 502,500 1.900% | 201,000 (+66.67%) | Filing History |
| 2025-05-15 4:41 pm Unchanged | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management LLC | 2,220,000 8.120% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management LLC | 2,220,000 8.120% | 1,710,717 (+335.91%) | Filing History |
| 2025-05-15 3:53 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | ARMISTICE CAPITAL LLC | 1,439,812 4.990% | 903,802 (+168.62%) | Filing History |
| 2025-05-07 4:26 pm Sale | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | 8VC Fund I, L.P. | 253,755 1.000% | -1 (-0.00%) | Filing History |
| 2025-03-17 6:35 pm Purchase | 2025-03-10 | 13D | Senti Biosciences, Inc. SNTI | Bayer HealthCare LLC | 6,142,848 19.990% | 5,554,999 (+944.97%) | Filing History |
| 2025-03-17 3:01 pm Unchanged | 2025-03-06 | 13D | Senti Biosciences, Inc. SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 0 (Unchanged) | Filing History |
| 2025-03-13 4:31 pm Purchase | 2025-03-06 | 13D | Senti Biosciences, Inc. SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 9,777,000 (New Position) | Filing History |
| 2025-03-10 7:00 pm Purchase | 2025-03-06 | 13D | Senti Biosciences, Inc. SNTI | New Enterprise Associates 15, L.P. | 3,775,615 14.500% | 3,333,000 (+753.02%) | Filing History |
| 2025-02-14 4:56 pm Purchase | 2024-12-31 | 13G | Senti Biosciences, Inc. SNTI | ARMISTICE CAPITAL LLC | 536,010 9.990% | 536,010 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management LLC | 509,283 9.990% | 509,283 (New Position) | Filing History |
| 2025-02-14 4:31 pm Purchase | 2024-12-02 | 13G | Senti Biosciences, Inc. SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 301,500 5.914% | 301,500 (New Position) | Filing History |
| 2024-12-04 7:08 pm Purchase | 2024-12-02 | 13D | Senti Biosciences, Inc. SNTI | New Enterprise Associates 15, L.P. | 442,615 9.600% | 442,615 (New Position) | Filing History |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Senti Biosciences, Inc. SNTI | PRICE T ROWE ASSOCIATES INC | 355,402 8.100% | 355,402 (New Position) | Filing History |
| 2023-02-14 11:52 am Unchanged | 2022-12-31 | 13G | Senti Biosciences, Inc. SNTI | Sculptor Capital LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:14 pm Purchase | 2022-12-31 | 13G | Senti Biosciences, Inc. SNTI | Bayer HealthCare LLC | 587,849 13.400% | 587,849 (New Position) | Filing History |
| 2023-02-10 4:09 pm Unchanged | 2022-12-31 | 13G | Senti Biosciences, Inc. SNTI | Woodline Partners LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-09 4:06 pm Purchase | 2022-12-30 | 13G | Senti Biosciences, Inc. SNTI | MORGAN STANLEY MS | 24,986 0.600% | 24,986 (New Position) | Filing History |
| 2023-02-08 4:35 pm Purchase | 2022-06-08 | 13G | Senti Biosciences, Inc. SNTI | 8VC Fund I, L.P. | 253,756 5.800% | 253,756 (New Position) | Filing History |
| 2022-07-15 5:24 pm Purchase | 2022-06-08 | 13D | Senti Biosciences, Inc. SNTI | New Enterprise Associates 15, L.P. | 442,615 10.100% | 442,615 (New Position) | Filing History |